Medscape CME Activity

Anaplasmosis, an emerging tickborne zoonosis, infrequently involves the central nervous system, and cerebrospinal fluid (CSF) profiles of anaplasmosis remain poorly characterized. We conducted a multisite retrospective study of patients hospitalized with anaplasmosis during November 1, 2014–November 29, 2024, in Minnesota and Wisconsin, USA, a hyperendemic region. Included patients had anaplasmosis confirmed by PCR on blood samples, exhibited neurologic symptoms, and had lumbar puncture procedures. Ten hospitalized patients met inclusion criteria, 6 with meningitis, 3 with meningoencephalitis, and 1 with encephalitis. CSF findings were within reference ranges for 5 patients; 4 patients demonstrated mild lymphocytic pleocytosis, but glucose and protein levels were within reference ranges. One patient underwent a traumatic lumbar puncture resulting in neutrophilic pleocytosis. CSF abnormalities did not correlate with neurologic severity, suggesting a cytokine-mediated process rather than direct central nervous system infection. All patients rapidly improved with doxycycline, highlighting the need for early recognition and empiric therapy for anaplasmosis.

Diagnosis of coccidioidomycosis is challenging and requires a high index of clinical suspicion. We estimated the incidence and duration of, and risk factors associated with, diagnostic delays and missed opportunities in the diagnosis of coccidioidomycosis. We conducted a retrospective analysis of health insurance claims data in the United States during 2001–2022 included in the Merative MarketScan Databases. Using a case-crossover design and a bootstrapping approach, we estimated the number of excess visits for coccidioidomycosis-related symptoms before diagnosis. We also evaluated potential factors associated with delay. We estimated that almost 60% of patients experienced >1 missed opportunity for diagnosis; the average diagnostic delay was 29.69 (95% CI 28.25–31.18) days. Missed opportunities were predominantly observed in outpatient settings (73%) and were significantly associated with older age, rural residence, underlying pulmonary conditions, and prescriptions for antibiotics or inhalers. Diagnostic delays for coccidioidomycosis are common, and addressing such delays could improve clinical outcomes.

Snowshoe hare virus (SSHV) is an arbovirus in the California serogroup known to circulate throughout Canada and northern latitudes of the United States. The clinical spectrum of SSHV infection ranges from asymptomatic or mild febrile illness to neuroinvasive disease; neuroinvasive disease occurs more often in children and young adults. We describe a cluster of confirmed and probable SSHV meningoencephalitis cases in 3 children from Whistler, British Columbia, Canada, in the summer of 2024. We highlight the shared epidemiology, clinical manifestations, serologic diagnostic methods, and outcomes for the cases. All 3 children acquired the infection locally and made a full recovery. This case series suggests underrecognized SSHV infection prevalence that warrants enhanced surveillance and review of existing diagnostic algorithms. California serogroup viruses, including SSHV, should be recognized as a potential cause of neuroinvasive disease in North America during mosquito season, particularly when initial diagnostic testing is inconclusive.

Blastomyces urine antigen testing is a sensitive blastomycosis diagnostic method, but its utility for active case identification during outbreaks is unknown. We evaluated urine antigen testing for identifying blastomycosis cases during a 2023 outbreak at a Michigan, USA, paper mill and assessed demographic and clinical factors associated with test positivity. Approximately 2 months after the outbreak was recognized, we collected work and health information for 603 employees; 95% (n = 578) underwent urine antigen testing and 9% (n = 52) tested positive, including 25 previously undetected cases. Blastomycosis-like symptoms were associated with test positivity (p<0.001), but 10% of employees with positive results were asymptomatic. Recent hospitalization for blastomycosis was associated with test positivity (p = 0.02) and higher antigen levels. Further research into urine antigen testing is needed clarify its suitability for detecting mild and asymptomatic infections during outbreak investigations. Urine antigen testing had high acceptability among employees and effectively identified additional cases.

Group A Streptococcus (GAS) causes a variety of diseases in humans but is not widely appreciated as a cause of meningitis. During 1997–2022, ten sites participating in the Active Bacterial Core Surveillance network in the United States identified GAS meningitis cases. We calculated annual incidence and case-fatality rates (CFRs) for 320 of those cases and determined antimicrobial resistance by whole-genome sequencing. Annual incidence of GAS meningitis ranged from 0.02 to 0.07 cases/100,000 persons. Children <1 year of age had the highest average annual incidence, 0.23 cases/100,000 children. GAS meningitis had a higher CFR (19.4%) than meningitis caused by group B Streptococcus, Streptococcus pneumoniae, Neisseria meningitidis, or Haemophilus influenzae. Clindamycin resistance among GAS meningitis isolates increased from 3.2% during 1997–2002 to 17.7% during 2018–2022. Clinicians should be aware that meningitis is an uncommon but severe manifestation of invasive GAS and has a higher CFR than more established meningitis etiologies.

Reports of ocular manifestations of Lyme disease (LD) are uncommon, and signs and symptoms may be overlooked by physicians. We conducted a retrospective case series of ocular LD reported during 1988–2025. Among 27 published reports in PubMed, we noted that, in 38 cases, the most common ocular manifestation was uveitis, representing 45% of cases, followed by optic neuritis and cranial nerve palsies (including trochlear and abducens). Not all cases met Centers for Disease Control and Prevention surveillance guidelines for LD, given that some case reports were published before the current guidelines. Cases that provided microbiologic proof were 2 anterior uveitis cases, 1 case of anterior uveitis with abducens’s nerve palsy, 1 case of intermediate uveitis, and 1 case of intranuclear ophthalmoplegia. Ocular LD can have a broad variety of manifestations; therefore, physicians should be aware of those manifestations and obtain microbiologic proof for a more definitive diagnosis and epidemiologic value when possible.